Jane Street Group LLC Has $237,000 Stock Position in PepGen Inc. (NASDAQ:PEPG)

Jane Street Group LLC grew its position in PepGen Inc. (NASDAQ:PEPG) by 29.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 27,748 shares of the company’s stock after acquiring an additional 6,254 shares during the period. Jane Street Group LLC’s holdings in PepGen were worth $237,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Suvretta Capital Management LLC grew its holdings in shares of PepGen by 9.2% in the 3rd quarter. Suvretta Capital Management LLC now owns 1,660,932 shares of the company’s stock valued at $14,201,000 after buying an additional 140,000 shares during the period. Sofinnova Investments Inc. grew its holdings in shares of PepGen by 11.4% in the 2nd quarter. Sofinnova Investments Inc. now owns 561,128 shares of the company’s stock valued at $8,956,000 after buying an additional 57,504 shares during the period. Janus Henderson Group PLC grew its holdings in shares of PepGen by 331.2% in the 3rd quarter. Janus Henderson Group PLC now owns 2,336,516 shares of the company’s stock valued at $20,012,000 after buying an additional 1,794,641 shares during the period. American Century Companies Inc. grew its holdings in shares of PepGen by 19.9% in the 2nd quarter. American Century Companies Inc. now owns 20,028 shares of the company’s stock valued at $320,000 after buying an additional 3,326 shares during the period. Finally, Wellington Management Group LLP grew its holdings in shares of PepGen by 76.9% in the 3rd quarter. Wellington Management Group LLP now owns 40,517 shares of the company’s stock valued at $346,000 after buying an additional 17,618 shares during the period. Institutional investors and hedge funds own 58.01% of the company’s stock.

PepGen Price Performance

Shares of NASDAQ:PEPG opened at $2.97 on Friday. The company’s 50-day moving average price is $4.65 and its two-hundred day moving average price is $8.88. PepGen Inc. has a one year low of $2.90 and a one year high of $19.30. The stock has a market capitalization of $96.81 million, a PE ratio of -1.00 and a beta of 1.66.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PEPG. Wedbush decreased their price target on shares of PepGen from $19.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, November 8th. HC Wainwright reaffirmed a “buy” rating and issued a $26.00 price objective on shares of PepGen in a research report on Friday, November 8th. Finally, Bank of America cut shares of PepGen from a “neutral” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research report on Monday, December 16th.

PepGen Company Profile

PepGen Inc, a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients.